赵杨 (邮箱: y.zhao@njucm.edu.cn)，博士，教授，博士生导师，江苏省特聘教授，中华中医药学会青年人才托举A类获得者。博士毕业于澳大利亚悉尼大学，后于澳大利亚百年研究所从事博士后研究。
主要从事血管紊乱相关疾病发病机制及中医药防治策略研究。主持国家自然科学基金2项、江苏省特聘教授自然科学类资助项目、江苏省高等学校基础科学（自然科学）研究A类重大项目、南京市留学人员科技创新项目A类、Sydney Medical School Kick Start Grants Program等科研基金项目。先后在第14届世界炎症大会等6个国际性会议上口头发言，获得World Congress on Inflammation 2019 Award等4项国际性科研奖励。在Circulation Research, Cancer Research, PLoS Biology, APSB, Pharmacological Research, Cancer Letters 等国际知名SCI期刊发表论文50余篇，其中以第一/通讯作者身份发表33篇，授权专利2项。担任Frontiers in Immunology专刊主编，Cancer Research, EBioMedicine, APSB, Journal of Advanced Research等杂志审稿人，同时还担任中华中医药学会实验药理分会委员、江苏省免疫学会免疫与代谢专业委员会常务委员、江苏省药理学会中药药理专业委员会和青年委员会委员、澳大利亚Sydney Catalyst委员会委员、澳大利亚血管生物学会委员、国家自然科学基金评审专家、国家公派出国留学评审专家、教育部学位论文评审专家等学术兼职。
代表性研究论文
[1]. Cheng Qian#, Yueke Zhou#, Teng Zhang, Guanglu Dong, Mengyao Song, Yu Tang, Zhonghong Wei, Suyun Yu, Qiuhong Shen, Wenxing Chen, Jaesung P. Choi, Juming Yan, Chongjing Zhong, Li Wan, Jia Li, Aiyun Wang*, Yin Lu*, Yang Zhao*. Targeting PKM2 signaling cascade with salvianic acid A normalizes tumor blood vessels to facilitate chemotherapeutic drug delivery. Acta Pharmaceutica Sinica B. 2024, doi.org/10.1016/j.apsb.2024.02.003.
[2]. Weiwei Zheng#, Peiliang Shen#, Chang Yu#, Yu Tang, Cheng Qian, Chunmei Yang, Mingliang Gao, Yuanyuan Wu, Suyun Yu, Weiwei Tang, Guiping Wan, Aiyun Wang*, Yin Lu*, Yang Zhao*. Ginsenoside Rh1, a novel casein kinase II subunit alpha (CK2 α) inhibitor, retards metastasis via disrupting HHEX/CCL20 signaling cascade involved in tumor cell extravasation across endothelial barrier. Pharmacological Research, 2023, 106986.
[3]. Cheng Qian#, Chunmei Yang#, Yu Tang#, Weiwei Zheng, Yueke Zhou, Shan Zhang, Mengyao Song, Peng Cheng, Zhonghong Wei, Chongjin Zhong, Li Wan, Aiyun Wang*, Yang Zhao*, Yin Lu*. Pharmacological manipulation of Ezh2 with Salvianolic acid B results in tumor vascular normalization and synergizes with cisplatin and T cell-mediated immunotherapy. Pharmacological Research, 2022, 182:106333.
[4]. Yang Zhao, Jia Li, Ka Ka Ting, Jinbiao Chen, Paul Coleman, Ken Liu, Li Wan, Thorleif Moller, Mathew Vadas and Jennifer Gamble*. The VE-Cadherin/β-catenin signalling axis regulates immune cell infiltration into tumours. Cancer Letters, 2021, 496(1):1-15.
[5]. Yang Zhao, Xiangrong Yu and Jia Li*. Manipulation of immune-vascular crosstalk: new strategies towards cancer treatment. Acta Pharmaceutica Sinica B. 2020, 10(11):2018-2036.
